Dementia and Neurocognitive Disorders (대한치매학회지)

Korean Dementia Association (대한치매학회)
권호 표지
DOI QR코드

DOI QR Code

Association between Alzheimer's Disease and Cancer Risk in South Korea: an 11-year Nationwide Population-Based Study

  • Lee, Ji Eun (Department of Neurology, National Health Insurance Service Ilsan Hospital) ;
  • Kim, DongWook (Institute of Health Insurance & Clinical Research, National Health Insurance Service Ilsan Hospital) ;
  • Lee, Jun Hong (Department of Neurology, National Health Insurance Service Ilsan Hospital)
  • Received : 2018.10.31
  • Accepted : 2018.12.20
  • Published : 2018.12.31
⟨ Previous Next ⟩

Abstract

Background and Purpose: Previous studies have suggested a decreased cancer risk among patients with Alzheimer's disease (AD). There remains a lack of data on the specific types of cancer and risk factors for developing cancer in AD. We evaluated the association between AD and cancer risk, and we examined specific types of cancer. Methods: A population-based longitudinal study was conducted using the National Health Insurance Service-Senior cohort for 2002-2013. A total of 4,408 AD patients were included in the study, as were 19,150 matched controls. Potential associations between the risk of cancer and AD were analyzed using Cox proportional hazard regressions. Results: Cancer developed in 12.3% of the AD group patients and in 18.5% of control group subjects. AD was associated with a reduced risk of cancer (hazard ratio [HR], 0.70; 95% confidence intervals, 0.64-0.78). The risk of head and neck cancers was significantly reduced (HR, 0.49), as were risks for cancers of the digestive tract, including stomach cancer (HR, 0.42), colorectal cancer (HR, 0.61), liver and biliary tract cancers (HR, 0.68), and pancreatic cancer (HR, 0.55). Lung and prostate cancer risks were also significantly lower for the AD group (HR, 0.52 and HR, 0.72, respectively). Conclusions: Our results showed an inverse association between AD and cancer. Further research involving a large number of patients in a hospital based-study is needed to address the biological associations between cancer development and dementia, including AD.

Keywords

References

  1. Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol 2003;60:1119-1122. https://doi.org/10.1001/archneur.60.8.1119
  2. Ma LL, Yu JT, Wang HF, Meng XF, Tan CC, Wang C, et al. Association between cancer and Alzheimer's disease: systematic review and meta-analysis. J Alzheimers Dis 2014;42:565-573. https://doi.org/10.3233/JAD-140168
  3. Kukull WA, Ganguli M. Epidemiology of dementia: concepts and overview. Neurol Clin 2000;18:923-950. https://doi.org/10.1016/S0733-8619(05)70233-4
  4. Ou SM, Lee YJ, Hu YW, Liu CJ, Chen TJ, Fuh JL, et al. Does Alzheimer's disease protect against cancers? A nationwide population-based study. Neuroepidemiology 2013;40:42-49. https://doi.org/10.1159/000341411
  5. Hoskin DW, Ramamoorthy A. Studies on anticancer activities of antimicrobial peptides. Biochim Biophys Acta 2008;1778:357-375. https://doi.org/10.1016/j.bbamem.2007.11.008
  6. Schuller HM. Is cancer triggered by altered signalling of nicotinic acetylcholine receptors? Nat Rev Cancer 2009;9:195-205. https://doi.org/10.1038/nrc2590
  7. Roe CM, Behrens MI, Xiong C, Miller JP, Morris JC. Alzheimer disease and cancer. Neurology 2005;64:895-898. https://doi.org/10.1212/01.WNL.0000152889.94785.51
  8. Roe CM, Fitzpatrick AL, Xiong C, Sieh W, Kuller L, Miller JP, et al. Cancer linked to Alzheimer disease but not vascular dementia. Neurology 2010;74:106-112. https://doi.org/10.1212/WNL.0b013e3181c91873
  9. Musicco M, Adorni F, Di Santo S, Prinelli F, Pettenati C, Caltagirone C, et al. Inverse occurrence of cancer and Alzheimer disease: a population-based incidence study. Neurology 2013;81:322-328. https://doi.org/10.1212/WNL.0b013e31829c5ec1
  10. Driver JA, Beiser A, Au R, Kreger BE, Splansky GL, Kurth T, et al. Inverse association between cancer and Alzheimer's disease: results from the Framingham Heart Study. BMJ 2012;344:e1442. https://doi.org/10.1136/bmj.e1442
  11. Shi HB, Tang B, Liu YW, Wang XF, Chen GJ. Alzheimer disease and cancer risk: a meta-analysis. J Cancer Res Clin Oncol 2015;141:485-494. https://doi.org/10.1007/s00432-014-1773-5
  12. Realmuto S, Cinturino A, Arnao V, Mazzola MA, Cupidi C, Aridon P, et al. Tumor diagnosis preceding Alzheimer's disease onset: is there a link between cancer and Alzheimer's disease? J Alzheimers Dis 2012;31:177-182. https://doi.org/10.3233/JAD-2012-120184
  13. Lin HL, Lin HC, Tseng YF, Chen SC, Hsu CY. Inverse association between cancer and dementia: a population-based registry study in Taiwan. Alzheimer Dis Assoc Disord 2016;30:118-122. https://doi.org/10.1097/WAD.0000000000000116
  14. Frain L, Swanson D, Cho K, Gagnon D, Lu KP, Betensky RA, et al. Association of cancer and Alzheimer's disease risk in a national cohort of veterans. Alzheimers Dement 2017;13:1364-1370. https://doi.org/10.1016/j.jalz.2017.04.012
  15. Attner B, Lithman T, Noreen D, Olsson H. Low cancer rates among patients with dementia in a population-based register study in Sweden. Dement Geriatr Cogn Disord 2010;30:39-42. https://doi.org/10.1159/000315509
  16. Yamada M, Sasaki H, Mimori Y, Kasagi F, Sudoh S, Ikeda J, et al. Prevalence and risks of dementia in the Japanese population: RERF's adult health study Hiroshima subjects. J Am Geriatr Soc 1999;47:189-195. https://doi.org/10.1111/j.1532-5415.1999.tb04577.x
  17. Catala-Lopez F, Crespo-Facorro B, Vieta E, Valderas JM, Valencia A, Tabares-Seisdedos R. Alzheimer's disease and cancer: current epidemiological evidence for a mutual protection. Neuroepidemiology 2014;42:121-122. https://doi.org/10.1159/000355899
  18. National Health Insurance Service. 2016 National Health Screening Statistical Yearbook. Wonju: National Health Insurance Service, 2017;1-860.
  19. Ben Q, Xu M, Ning X, Liu J, Hong S, Huang W, et al. Diabetes mellitus and risk of pancreatic cancer: a meta-analysis of cohort studies. Eur J Cancer 2011;47:1928-1937. https://doi.org/10.1016/j.ejca.2011.03.003
  20. Wong G, Howard K, Tong A, Craig JC. Cancer screening in people who have chronic disease: the example of kidney disease. Semin Dial 2011;24:72-78. https://doi.org/10.1111/j.1525-139X.2010.00804.x
  21. Kornum JB, Svaerke C, Thomsen RW, Lange P, Sorensen HT. Chronic obstructive pulmonary disease and cancer risk: a Danish nationwide cohort study. Respir Med 2012;106:845-852. https://doi.org/10.1016/j.rmed.2011.12.009
  22. Bennett DA. Is there a link between cancer and Alzheimer disease? Neurology 2010.75:1216-1217.
  23. Behrens MI, Lendon C, Roe CM. A common biological mechanism in cancer and Alzheimer's disease? Curr Alzheimer Res 2009;6:196-204. https://doi.org/10.2174/156720509788486608
  24. Plun-Favreau H, Lewis PA, Hardy J, Martins LM, Wood NW. Cancer and neurodegeneration: between the devil and the deep blue sea. PLoS Genet 2010;6:e1001257. https://doi.org/10.1371/journal.pgen.1001257
  25. Ibanez K, Boullosa C, Tabares-Seisdedos R, Baudot A, Valencia A. Molecular evidence for the inverse comorbidity between central nervous system disorders and cancers detected by transcriptomic meta-analyses. PLoS Genet 2014;10:e1004173. https://doi.org/10.1371/journal.pgen.1004173
  26. Bao L, Kimzey A, Sauter G, Sowadski JM, Lu KP, Wang DG. Prevalent overexpression of prolyl isomerase Pin1 in human cancers. Am J Pathol 2004;164:1727-1737. https://doi.org/10.1016/S0002-9440(10)63731-5
  27. van Heemst D, Mooijaart SP, Beekman M, Schreuder J, de Craen AJ, Brandt BW, et al. Variation in the human TP53 gene affects old age survival and cancer mortality. Exp Gerontol 2005;40:11-15. https://doi.org/10.1016/j.exger.2004.10.001
  28. Inestrosa NC, Montecinos-Oliva C, Fuenzalida M. Wnt signaling: role in Alzheimer disease and schizophrenia. J Neuroimmune Pharmacol 2012;7:788-807. https://doi.org/10.1007/s11481-012-9417-5
  29. Catala-Lopez F, Suarez-Pinilla M, Suarez-Pinilla P, Valderas JM, Gomez-Beneyto M, Martinez S, et al. Inverse and direct cancer comorbidity in people with central nervous system disorders: a meta-analysis of cancer incidence in 577,013 participants of 50 observational studies. Psychother Psychosom 2014;83:89-105. https://doi.org/10.1159/000356498
  30. Bajaj A, Driver JA, Schernhammer ES. Parkinson's disease and cancer risk: a systematic review and meta-analysis. Cancer Causes Control 2010;21:697-707. https://doi.org/10.1007/s10552-009-9497-6
  31. Sun LM, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH. Analysis of Parkinson's disease and subsequent cancer risk in Taiwan: a nationwide population-based cohort study. Neuroepidemiology 2011;37:114-119. https://doi.org/10.1159/000331489
  32. Kang YW, Na DL, Hahn SH. A validity study on the Korean mini-mental state examination (K-MMSE) in dementia patients. J Korean Neurol Assoc 1997;15:300-308.
  33. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43:2412-2414.
  34. Reisberg B, Ferris SH, de Leon MJ, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 1982;139:1136-1139. https://doi.org/10.1176/ajp.139.9.1136

Cited by

  1. The Identification of Critical m 6 A RNA Methylation Regulators as Malignant Prognosis Factors in Prostate Adenocarcinoma vol.11, pp.None, 2018, https://doi.org/10.3389/fgene.2020.602485
  2. Exploring prior diseases associated with pancreatic cancer vol.45, pp.5, 2018, https://doi.org/10.1016/j.currproblcancer.2021.100707